Taya M, Merenbakh-Lamin K, Zubkov A, Honig Z, et al. Beyond endocrine resistance: estrogen receptor (ESR1) activating mutations mediate chemotherapy resistance through the JNK/c-Jun MDR1 pathway in breast cancer. Breast Cancer Res Treat 2024 Oct 29. doi: 10.1007/s10549-024-07507.
PMID: 39470848